|
|||||
|
|
Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator |
|
| Authors: | C. E. McCarthy M. O'Brien J. Andrews J. M. Zoland E. Macasiray W. Wong C. Lo B. Glader J. Tamaresis M. Jeng |
| Affiliation: | 1. Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA;2. Cancer and Blood Disorders Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA;3. Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA;4. Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, CA, USA |
| Abstract: | |
| Keywords: | central venous catheter haemophilia infection prophylaxis recombinant tissue plasminogen activator |